Streetbeat News

Stock Prices

VTLE

Analysts' ratings for Vital Energy (NYSE:VTLE) over the last quarter show a mix of bullish and bearish sentiments. The average 12-month price target has slightly increased to $59.4. Key analysts have adjusted their ratings and price targets, reflecting their evolving views on the company's performance. Vital Energy has shown strong revenue growth but faces challenges with profitability, return on equity, and debt management.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 9:00 pm

FTRE

Over the past three months, 8 analysts have reviewed Fortrea Holdings (NASDAQ:FTRE), with opinions ranging from somewhat bullish to somewhat bearish. The average 12-month price target has decreased by 21.87% to $28.75. Analysts have recently adjusted their ratings and price targets, reflecting a cautious outlook on the company's financial performance and growth prospects.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 9:00 pm

ILMN

Illumina (NASDAQ:ILMN) has significantly outperformed the market over the past 20 years, delivering an average annual return of 20.85%. A $1000 investment in Illumina 20 years ago would be worth $46,623.49 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 9:00 pm

NTRA

Natera (NASDAQ:NTRA) has significantly outperformed the market over the past 5 years, delivering an average annual return of 31.07%. A $100 investment in NTRA 5 years ago would now be worth $386.36. The company's current market capitalization is $12.47 billion.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 9:00 pm

AMX

America Movil (NYSE:AMX) has been analyzed by 5 analysts in the last three months, showing a range of perspectives from bullish to indifferent. The average 12-month price target is $19.94, with a high of $22.60 and a low of $17.20. Recent analyst actions include both raises and lowers in ratings and price targets. America Movil faces revenue challenges but shows strong profitability, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 9:00 pm

AMGN

HRTS

LLY

NVO

PFE

TERN

VKTX

Eli Lilly and Novo Nordisk faced significant stock declines as new competitors entered the weight-loss drug market. Pfizer and Roche announced advancements in obesity treatments, challenging the duopoly of Eli Lilly's Zepbound and Novo Nordisk's Wegovy. The Tema GLP-1, Obesity and Cardiometabolic ETF (HRTS) fund reflects a diversified approach, investing in emerging GLP-1 players like Amgen, Terns Pharmaceuticals, and Viking Therapeutics.

Portfolio Pulse from Piero Cingari

July 18, 2024 | 8:59 pm

SCHL

Scholastic Corporation (NASDAQ:SCHL) reported worse-than-expected Q4 results, with earnings and sales significantly missing analyst estimates. The company also provided a mixed outlook for fiscal 2025.

Portfolio Pulse from Erica Kollmann

July 18, 2024 | 8:58 pm

NFLX

Netflix has announced a target of a 26% full-year operating margin during an investor call.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 8:53 pm

PPG

PPG Industries Inc (NYSE:PPG) shares fell in after-hours trading following the release of their Q2 earnings report, which showed a revenue miss and a cut in guidance. Despite beating earnings per share estimates, the company lowered its full-year outlook, citing weak global automotive builds and soft industrial production.

Portfolio Pulse from Adam Eckert

July 18, 2024 | 8:48 pm

KARO

Karooooo has projected its FY25 EPS to be between ZAR27.50 and ZAR31.00.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 8:47 pm